S3 Ep29: A Simple Blood Test To Detect Lung Cancer w/ Allan Syms Chairman Cizzle Biotech

In this podcast Mark Fairbairn & Kenny Russell talk to Allan Syms the Exceutive Chairman of Cizzle Biotech. The compnay are working on developing a blood test to detect early stage lung cancer. With 13 years of research already behind them, their IPO June 2021 opened the way to develop the science into a marketable product.  00:00 - Introduction to Allan 09:40 - Allan's Interest in Science  5:14 - The Jump into Industry 22:56 - Working for Big Pharma 25:35 - Scientist or Business Man? 29:16 - Failures Along the Way 32:07 - Allan's Joins Cizzle  35:58 - The Cizzle Investment Case